Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (17) Daniel, Peter Prof. Dr. (1) Hinz, Michael Dr. (1) Kammertöns, Thomas Dr. (2) Kopp, Joachim Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (8) Pezzutto, Antonio Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (6) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (6) Walther, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (4) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (8) (-) Leisegang, Matthias Prof. Dr. rer. nat. (2) (-) Biologie maligner Lymphome (8) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (2) Translationale Onkologie solider Tumore (1) 1999 (1) 2000 (1) 2002 (1) (-) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (5) 2007 (2) 2008 (2) 2009 (3) (-) 2010 (2) 2011 (5) 2012 (2) 2013 (2) 2014 (2) 2015 (4) 2016 (2) 2017 (4) 2018 (2) 2020 (5) 2021 (3) 2022 (5) 2023 (6) 2024 (1) 10 Ergebnisse: Active Filter: Janz, Martin Dr.Leisegang, Matthias Prof. Dr. rer. nat.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 200320062010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner 01. Mai 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Mai 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Januar 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer 01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
01. Mai 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Mai 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Januar 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer
01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken